Zai Lab Limited (ZLAB) has a negative trailing P/E of -13.2, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 124.6 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -7.57%, forward earnings yield 0.80%. PEG 0.20 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
Overall SharesGrow Score: 61/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -0.7 | -0.01 | -0.51 | 0.00 | - |
| 2017 | -1.0 | 0.02 | 0.21 | 0.00 | - |
| 2018 | -0.9 | -0.06 | 0.49 | 943.67 | - |
| 2019 | -1.4 | -0.09 | 0.91 | 20.62 | - |
| 2020 | -3.9 | -0.28 | 0.90 | 21.47 | - |
| 2021 | -0.8 | -0.01 | 0.42 | 4.05 | - |
| 2022 | -0.7 | 0.02 | 0.28 | 1.37 | - |
| 2023 | -0.8 | 0.03 | 0.33 | 0.99 | - |
| 2024 | -10.1 | 0.11 | 3.08 | 6.50 | - |
| 2025 | -11.0 | 0.29 | 2.70 | 4.20 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-3.97 | $0.00 | $-37.51M | - |
| 2017 | $-2.32 | $0.00 | $-50.38M | - |
| 2018 | $-2.64 | $129.45K | $-139.07M | -107433.6% |
| 2019 | $-3.03 | $12.98M | $-183.37M | -1412.2% |
| 2020 | $-3.46 | $48.96M | $-298.16M | -609% |
| 2021 | $-7.58 | $144.31M | $-692.44M | -479.8% |
| 2022 | $-4.63 | $215.04M | $-481.99M | -224.1% |
| 2023 | $-3.46 | $266.72M | $-334.62M | -125.5% |
| 2024 | $-2.60 | $398.99M | $-257.1M | -64.4% |
| 2025 | $-1.60 | $460.16M | $-175.54M | -38.1% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-1.72 | $-2.16 – $-1.41 | $501.86M | $487.49M – $518.27M | 7 |
| 2027 | $-1.14 | $-1.85 – $-0.68 | $646.26M | $628.19M – $659.91M | 6 |
| 2028 | $-0.79 | $-1.30 – $-0.20 | $780.52M | $773.61M – $787.43M | 3 |
| 2029 | $0.18 | $0.16 – $0.20 | $1.09B | $1.02B – $1.2B | 1 |
| 2030 | $1.30 | $1.19 – $1.47 | $1.43B | $1.34B – $1.57B | 1 |
